Finance

Lists
Outlook: 50.0% bullish·25.0% bearish
Go to analysis
PIII:NASDAQ
P3 Health Partners Inc
$2.70
-1.82%
(-0.050) 1D
Nov 13, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PIII...
Open
$2.77
High
$2.81
Low
$2.51
Mkt. cap
19.61M
Avg. vol.
43.13K
Volume
29.46K
52-wk high
$16.89
52-wk low
$1.52
EPS
-$23.44
Beta
1.81
Shares outstanding
4.02M
No. of employees
320
Open
$2.77
High
$2.81
Low
$2.51
Mkt. cap
19.61M
Avg. vol.
43.13K
Volume
29.46K
52-wk high
$16.89
52-wk low
$1.52
EPS
-$23.44
Beta
1.81
Shares outstanding
4.02M
No. of employees
320
News stories
From web sources and news partners
About P3 Health Partners Inc
CEO-
Employees320
Founded2020
HeadquartersChicago, Illinois, United States
SectorHealth Care
IndustryHealth care provider
Websitep3hp.org
Analyst ratings
Based on 2 analysts giving stock ratings to PIII in the past 3 months
Buy
Buy
1
Hold
1
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for PIII in the last 3 months.
Highest
Current $2.70
$11.50 (+325.93%)
Average
$7.75 (+187.04%)
Lowest
$4.00 (+48.15%)
Analyst
Recommendation
Action
Price target
Projected
Date
Gary Taylor
TD Cowen
Hold
Reiterated
$4.00
+48.1%
11/11/2026
Ben Haynor
Lake Street
Buy
Maintained
$11.50
+325.9%
11/10/2026
Ryan Langston
TD Cowen
Hold
Maintained
$13.00
+381.5%
08/26/2026
Daniel Brims
Lake Street
Buy
Reiterated
$962.00
+35,529.6%
05/15/2026
David Larsen
BTIG
Hold
Reiterated
-
-
11/14/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
384.81M
386.39M
386.38M
396.34M
Cost of goods sold
426.06M
336.02M
300.38M
346.00M
Cost of revenue
426.06M
336.02M
300.38M
346.00M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
36.21M
25.77M
32.39M
34.28M
Operating expense
112.62M
42.13M
44.78M
27.36M
Total operating expenses
538.68M
378.15M
345.16M
373.36M
Operating income
-153.87M
8.24M
41.23M
22.98M
Other non operating income
2.91M
572.00K
-16.45M
12.86M
EBT including unusual items
-166.75M
-7.96M
16.92M
30.80M
EBT excluding unusual items
-166.59M
-7.96M
16.92M
30.80M
Income tax expense
-1.04M
-11.00M
1.26M
23.00K
Effective tax rate
0.62%
138.21%
7.48%
0.07%
Other operating expenses
55.41M
-4.72M
-8.66M
-27.95M
Net income
-75.52M
1.22M
7.44M
15.62M
Net profit margin
-19.62%
0.32%
1.93%
3.94%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-15.64M
-16.77M
-7.86M
-5.04M
Net interest expenses
-15.64M
-16.77M
-7.86M
-5.04M
Depreciation and amortization charges
21.00M
21.07M
21.04M
21.04M
EBITDA
-132.87M
29.31M
62.27M
44.02M
Gain or loss from assets sale
-178.00K
-
127.00K
25.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps